Jacobs Levy Equity Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24M | Sell |
62,115
-26,557
| -30% | -$9.85M | 0.09% | 205 |
|
|
2026
Q1 | $26M | Sell |
88,672
-14,027
| -14% | -$4.61M | 0.11% | 188 |
|
|
2025
Q4 | $36M | Buy |
102,699
+10,599
| +12% | +$3.58M | 0.14% | 141 |
|
|
2025
Q3 | $29.8M | Sell |
92,100
-93,990
| -51% | -$29.2M | 0.12% | 162 |
|
|
2025
Q2 | $72.4M | Sell |
186,090
-207,579
| -53% | -$83.5M | 0.28% | 87 |
|
|
2025
Q1 | $171M | Sell |
393,669
-264,989
| -40% | -$106M | 0.68% | 24 |
|
|
2024
Q4 | $243M | Buy |
658,658
+102,306
| +18% | +$42.8M | 0.86% | 21 |
|
|
2024
Q3 | $289M | Buy |
556,352
+155,448
| +39% | +$83M | 1.12% | 8 |
|
|
2024
Q2 | $217M | Buy |
400,904
+28,912
| +8% | +$15.3M | 0.9% | 17 |
|
|
2024
Q1 | $193M | Buy |
371,992
+121,686
| +49% | +$60.5M | 0.86% | 20 |
|
|
2023
Q4 | $118M | Buy |
250,306
+100,706
| +67% | +$46.6M | 0.59% | 35 |
|
|
2023
Q3 | $65.1M | Sell |
149,600
-59,838
| -29% | -$27.1M | 0.39% | 65 |
|
|
2023
Q2 | $93.1M | Buy |
209,438
+117,169
| +127% | +$54.1M | 0.54% | 41 |
|
|
2023
Q1 | $42.4M | Buy |
92,269
+7,039
| +8% | +$3.35M | 0.26% | 97 |
|
|
2022
Q4 | $43.7M | Buy |
85,230
+7,778
| +10% | +$3.95M | 0.3% | 100 |
|
|
2022
Q3 | $35.2M | Sell |
77,452
-183,004
| -70% | -$87.6M | 0.28% | 101 |
|
|
2022
Q2 | $126M | Sell |
260,456
-94,886
| -27% | -$46.9M | 0.97% | 11 |
|
|
2022
Q1 | $175M | Sell |
355,342
-11,235
| -3% | -$5.14M | 1.17% | 7 |
|
|
2021
Q4 | $170M | Sell |
366,577
-57,282
| -14% | -$24.1M | 1.14% | 7 |
|
|
2021
Q3 | $158M | Buy |
423,859
+17,441
| +4% | +$6.63M | 1.06% | 7 |
|
|
2021
Q2 | $155M | Buy |
406,418
+37,845
| +10% | +$14.5M | 1.05% | 6 |
|
|
2021
Q1 | $132M | Buy |
368,573
+70,091
| +23% | +$22.5M | 1.02% | 7 |
|
|
2020
Q4 | $95.8M | Sell |
298,482
-85,835
| -22% | -$26.3M | 0.84% | 12 |
|
|
2020
Q3 | $103M | Buy |
384,317
+100,555
| +35% | +$27.1M | 1.07% | 8 |
|
|
2020
Q2 | $74.6M | Buy |
283,762
+60,861
| +27% | +$16.2M | 0.81% | 14 |
|
|
2020
Q1 | $50.6M | Sell |
222,901
-63,168
| -22% | -$17.2M | 0.65% | 30 |
|
|
2019
Q4 | $86.4M | Buy |
286,069
+71,794
| +34% | +$19.8M | 0.85% | 14 |
|
|
2019
Q3 | $51.4M | Buy |
214,275
+30,198
| +16% | +$8.27M | 0.63% | 26 |
|
|
2019
Q2 | $51.9M | Buy |
184,077
+64,626
| +54% | +$17.7M | 0.72% | 15 |
|
|
2019
Q1 | $34.3M | Sell |
119,451
-36,668
| -23% | -$10.6M | 0.49% | 41 |
|
|
2018
Q4 | $41M | Sell |
156,119
-14,099
| -8% | -$3.88M | 0.72% | 19 |
|
|
2018
Q3 | $46.6M | Buy |
170,218
+19,061
| +13% | +$4.95M | 0.66% | 16 |
|
|
2018
Q2 | $36M | Sell |
151,157
-17,089
| -10% | -$3.96M | 0.57% | 21 |
|
|
2018
Q1 | $37M | Buy |
168,246
+3,470
| +2% | +$815K | 0.62% | 15 |
|
|
2017
Q4 | $37.1M | Sell |
164,776
-11,580
| -7% | -$2.47M | 0.65% | 12 |
|
|
2017
Q3 | $33.5M | Buy |
176,356
+10,420
| +6% | +$1.98M | 0.65% | 13 |
|
|
2017
Q2 | $31.2M | Sell |
165,936
-41,810
| -20% | -$7.51M | 0.67% | 13 |
|
|
2017
Q1 | $34.4M | Sell |
207,746
-38,030
| -15% | -$6.05M | 0.69% | 13 |
|
|
2016
Q4 | $35.3M | Sell |
245,776
-45,143
| -16% | -$6.04M | 0.68% | 19 |
|
|
2016
Q3 | $36.5M | Buy |
290,919
+51,902
| +22% | +$6.7M | 0.65% | 23 |
|
|
2016
Q2 | $31.4M | Buy |
239,017
+57,640
| +32% | +$7.89M | 0.65% | 17 |
|
|
2016
Q1 | $25.2M | Sell |
181,377
-49,613
| -21% | -$6.63M | 0.53% | 37 |
|
|
2015
Q4 | $32.2M | Buy |
230,990
+200
| +0.1% | +$27.6K | 0.64% | 36 |
|
|
2015
Q3 | $32.3M | Buy |
230,790
+95,996
| +71% | +$14.4M | 0.66% | 34 |
|
|
2015
Q2 | $22.1M | Buy |
+134,794
| New | +$21.5M | 0.42% | 76 |
|
|
2015
Q1 | – | Sell |
-48,630
| Closed | -$6.11M | – | 811 |
|
|
2014
Q4 | $6.11M | Sell |
48,630
-74,410
| -60% | -$9.19M | 0.1% | 224 |
|
|
2014
Q3 | $14.7M | Sell |
123,040
-151,893
| -55% | -$17.4M | 0.25% | 133 |
|
|
2014
Q2 | $29.6M | Sell |
274,933
-44,737
| -14% | -$4.61M | 0.49% | 51 |
|
|
2014
Q1 | $31.8M | Sell |
319,670
-13,780
| -4% | -$1.25M | 0.53% | 45 |
|
|
2013
Q4 | $30.8M | Sell |
333,450
-10,190
| -3% | -$905K | 0.46% | 63 |
|
|
2013
Q3 | $28.7M | Sell |
343,640
-5,180
| -1% | -$444K | 0.49% | 55 |
|
|
2013
Q2 | $28.5M | Buy |
+348,820
| New | +$26.1M | 0.5% | 45 |
|
Other funds holding ELV
Jacobs Levy Equity Management's ELV Position: Q2 2026 in Review
Jacobs Levy Equity Management reduced its Elevance Health (ELV) stake by 30% in Q2 2026, selling an estimated $9.85M and leaving 62,115 shares worth $24M. The position accounts for 0.09% of the portfolio, ranked #205.
Jacobs Levy Equity Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $289M in Q3 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Jacobs Levy Equity Management held 62,115 shares of Elevance Health worth $24M as of Q2 2026.
- Jacobs Levy Equity Management sold 26,557 Elevance Health shares in Q2 2026, an estimated $9.85M.
- Elevance Health made up 0.09% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #205 holding.
- Jacobs Levy Equity Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Jacobs Levy Equity Management's Elevance Health position peaked at $289M in Q3 2024.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.